new version V2017

Alectinib ALK inhibitors
Description Results

RO5424802 - alectinib - CH5424802      

  • Group by...

pdf
TrialStudied treatmentControl treatmentpatientsROBResultNCT

lung cancer (metastatic)

ALEX, 2017alectinibcrizotinib1L Risk of bias ConclusiveNCT02075840
YO29449 ongoing alectinibcrizotinib - NCT02838420
MO29750 ongoing alectinibpremetrexed or docetaxel - NCT02604342



- About - Browse pathology | treatment - Site map - Credits Made with in Lyon - Contact us - Privacy policy - Licence Creative Commons